Skip to main content

Table 1 Baseline clinical characteristics

From: Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome

Variables

All patients

Low MAGE

High MAGE

p-value

(n = 417)

(n = 268)

(n = 149)

Age, years

66 (56–74)

66 (56–74)

68 (58–75)

0.275

Male, n (%)

348 (83)

219 (82)

129 (85)

0.201

Body mass index, kg/m2

26.8 (22.1–29.5)

24.5 (22.4–27.3)

23.9 (21.8–26.1)

0.010

STE-ACS, n (%)

292 (70)

191 (71)

101 (68)

0.457

Killip class > 1, n (%)

74 (18)

40 (15)

34 (23)

0.042

Infarct-related artery, n (%)

 Left anterior descending coronary artery, n (%)

229 (55)

150 (56)

79 (53)

0.562

 Left circumflex coronary artery, n (%)

45 (11)

29 (11)

16 (11)

0.979

 Right coronary artery, n (%)

143 (34)

89 (33)

54 (36)

0.532

Multivessel disease, n (%)

176 (42)

99 (37)

77 (52)

0.004

GRACE score > 140, n (%)

212 (51)

125 (47)

87 (58)

0.022

Hypertension, n (%)

255 (61)

155 (58)

100 (67)

0.063

Hypercholesteremia, n (%)

160 (38)

109 (41)

51 (34)

0.195

Systolic blood pressure on admission, mmHg

150 (125–170)

149 (125–167)

153 (124–177)

0.806

Heart rate on admission, bpm

76 (64–88)

76 (64–88)

76 (65–90)

0.575

Laboratory data

 Cre on admission, mg/dl

0.84 (0.72–1.00)

0.84 (0.73–0.98)

0.83 (0.71–1.02)

0.720

 eGFR on admission, %

67.9 (56.3–81.1)

67.3 (55.9–80.0)

70.4 (56.3–83.1)

0.091

 Peak level of CPK, IU/l

1129 (250–2864)

1130 (243–2870)

1129 (265–2838)

0.696

 BNP during stable phase, pg/ml

89.2 (35.5–192.7)

80.4 (35.4–171.4)

101.3 (37.7–209.1)

0.007

 hs-CRP during stable phase > 0.1355 mg/dl, n (%)

185 (44)

115 (43)

70 (47)

0.393

Lipid profile on admission

 LDL cholesterol, mg/dl

128 (105–152)

131 (108–155)

124 (102–148)

0.114

 HDL cholesterol, mg/dl

44 (37–52)

43 (37–51)

45 (37–52.5)

0.131

 Triglycerides, mg/dl

118 (75–185)

124 (78–197)

113 (70–162)

0.125

Medication on discharge, n (%)

 ACE-I or ARB

334 (80)

210 (78)

124 (83)

0.233

 β-blocker

275 (66)

175 (65)

100 (67)

0.708

 Statin

400 (96)

258 (96)

142 (95)

0.632

  1. STE-ACS ST-segment elevation acute coronary syndrome, GRACE score grobal registry of coronary event, Cre creatinine, eGFR estimated glomerular filtration rate, CPK creatine phosphokinase, BNP B-type natriuretic peptide, hs-CRP high sensitivity C-reactive protein, LDLC low-density lipoprotein cholesterol, HDLC high-density lipoprotein cholesterol, ACE-I angiotensin-converting enzyme-inhibitors, ARB angiotensin II receptor blockers